SK9772003A3 - R- a S-enantiomér 2-amino-1-(4-hydroxy-3- metánsulfónamidofenyl)etanolu, farmaceutický prostriedok s ich obsahom a ich použitie - Google Patents

R- a S-enantiomér 2-amino-1-(4-hydroxy-3- metánsulfónamidofenyl)etanolu, farmaceutický prostriedok s ich obsahom a ich použitie Download PDF

Info

Publication number
SK9772003A3
SK9772003A3 SK977-2003A SK9772003A SK9772003A3 SK 9772003 A3 SK9772003 A3 SK 9772003A3 SK 9772003 A SK9772003 A SK 9772003A SK 9772003 A3 SK9772003 A3 SK 9772003A3
Authority
SK
Slovakia
Prior art keywords
pharmaceutical
enantiomer
pharmaceutical composition
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
SK977-2003A
Other languages
English (en)
Slovak (sk)
Inventor
Pascale Pouzet
Franz Esser
Hisato Kitagawa
Naoki Ishiguro
Ikunobu Muramatsu
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Gmbh & Co. Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co. Kg
Publication of SK9772003A3 publication Critical patent/SK9772003A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/31Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms
    • C07C311/35Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK977-2003A 2001-02-01 2002-01-15 R- a S-enantiomér 2-amino-1-(4-hydroxy-3- metánsulfónamidofenyl)etanolu, farmaceutický prostriedok s ich obsahom a ich použitie SK9772003A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10104369A DE10104369A1 (de) 2001-02-01 2001-02-01 Verwendung von 2-Amino-(4-hydroxy-2-methansulfonamidophenyl)ethanol zur Behandlung der Harninkontinenz
PCT/EP2002/000311 WO2002060421A2 (en) 2001-02-01 2002-01-15 Use of 2-amino-1(4-hydroxy-2-methanesulphonamidophenyl)ethanol for treating urinary incontinence

Publications (1)

Publication Number Publication Date
SK9772003A3 true SK9772003A3 (sk) 2005-03-04

Family

ID=7672382

Family Applications (1)

Application Number Title Priority Date Filing Date
SK977-2003A SK9772003A3 (sk) 2001-02-01 2002-01-15 R- a S-enantiomér 2-amino-1-(4-hydroxy-3- metánsulfónamidofenyl)etanolu, farmaceutický prostriedok s ich obsahom a ich použitie

Country Status (26)

Country Link
EP (1) EP1363614B1 (de)
JP (1) JP2004517158A (de)
KR (1) KR20030075173A (de)
CN (1) CN1489459A (de)
AR (1) AR035778A1 (de)
AT (1) ATE293966T1 (de)
BG (1) BG108033A (de)
BR (1) BR0206854A (de)
CA (1) CA2434565A1 (de)
CZ (1) CZ20032097A3 (de)
DE (2) DE10104369A1 (de)
DK (1) DK1363614T3 (de)
EA (1) EA200300789A1 (de)
EC (1) ECSP034684A (de)
EE (1) EE200300357A (de)
ES (1) ES2240708T3 (de)
HU (1) HUP0302752A2 (de)
IL (1) IL156730A0 (de)
MX (1) MXPA03006816A (de)
NO (1) NO20033428L (de)
PL (1) PL361731A1 (de)
PT (1) PT1363614E (de)
SK (1) SK9772003A3 (de)
UY (1) UY27145A1 (de)
WO (1) WO2002060421A2 (de)
ZA (1) ZA200305201B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10352132A1 (de) * 2003-11-04 2005-06-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Zusammensetzung aus einem Beta-3-Adrenozeptor-Agonisten und einem Alpha Agonisten
CN113413393B (zh) * 2013-08-19 2025-03-04 塔里斯生物医药公司 多单元药物递送装置和方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US341584A (en) * 1886-05-11 Device foe
GB993584A (de) * 1962-01-24
DK0538469T3 (da) * 1990-02-07 1996-01-15 Nippon Shinyaku Co Ltd Sulfonanilidderivat og lægemiddel
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
WO1996038143A1 (en) * 1995-06-02 1996-12-05 Synaptic Pharmaceutical Corporation The use of alpha-1c-selective adrenoceptor agonists for the treatment of urinary incontinence
FR2737494B1 (fr) * 1995-08-04 1997-08-29 Synthelabo Derives de benzenesulfonamide, leur preparation et leur application en therapeutique
WO2000010557A1 (fr) * 1998-08-25 2000-03-02 Nippon Shinyaku Co.,Ltd. Preparations solides stabilisees

Also Published As

Publication number Publication date
AR035778A1 (es) 2004-07-14
EE200300357A (et) 2003-10-15
PL361731A1 (en) 2004-10-04
CN1489459A (zh) 2004-04-14
BG108033A (bg) 2004-12-30
IL156730A0 (en) 2004-02-08
DE60203882T2 (de) 2006-02-02
CZ20032097A3 (cs) 2003-12-17
DE60203882D1 (de) 2005-06-02
PT1363614E (pt) 2005-06-30
WO2002060421A2 (en) 2002-08-08
ZA200305201B (en) 2004-05-17
CA2434565A1 (en) 2002-08-08
KR20030075173A (ko) 2003-09-22
EP1363614A2 (de) 2003-11-26
UY27145A1 (es) 2002-08-30
HUP0302752A2 (hu) 2003-11-28
NO20033428L (no) 2003-09-30
ATE293966T1 (de) 2005-05-15
BR0206854A (pt) 2004-01-13
ES2240708T3 (es) 2005-10-16
WO2002060421A3 (en) 2002-12-19
DK1363614T3 (da) 2005-05-30
EP1363614B1 (de) 2005-04-27
JP2004517158A (ja) 2004-06-10
ECSP034684A (es) 2003-08-29
MXPA03006816A (es) 2004-05-14
DE10104369A1 (de) 2002-08-08
NO20033428D0 (no) 2003-07-31
EA200300789A1 (ru) 2004-02-26

Similar Documents

Publication Publication Date Title
RU2384333C2 (ru) Применение флибансерина для лечения предменструальных и иных сексуальных расстройств у женщин
US20070155679A1 (en) Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations
US20040234593A1 (en) Diphenhydramine tannate compositions and methods of use
ZA200503282B (en) Pharmaceutical composition comrpising a beta-3-adrenoceptor agonist and a serotonin and/or norepinephrine reuptake inhibitor and the use of said composition for treating bladder dysfunction
RU2238726C2 (ru) Применение саредутанта и его фармацевтически приемлемых солей для приготовления лекарственных продуктов, которые полезны при лечении или предупреждении больших депрессивных расстройств
EP1098636A1 (de) Feuchtgranulierungstechnik zur zubereitung einer stabilen parmazeutischen zusammensetzung
US6525084B2 (en) Stable pharmaceutical formulation
JP4166433B2 (ja) ホルモン依存性疾患治療剤
SK9772003A3 (sk) R- a S-enantiomér 2-amino-1-(4-hydroxy-3- metánsulfónamidofenyl)etanolu, farmaceutický prostriedok s ich obsahom a ich použitie
US6660772B2 (en) Use of 2-amino-1-(4-hydroxy-2-methanesulfonamidophenyl)ethanol for treating urinary incontinence
EP1333028A1 (de) 2'-halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidin-derivate und ihre Verwendung zur Behandlung der Harninkontinenz
RU2342133C2 (ru) Применение производных феноксиуксусной кислоты для лечения гиперактивности мочевого пузыря
SK14552001A3 (sk) Použitie osanetantu na prípravu farmaceutických prostriedkov použiteľných na liečenie porúch nálady
WO2003086346A1 (en) Diphenhydramine tannate compositions and methods of use
AU2002228045A1 (en) Use of 2-amino-1(4-hydroxy-2-methanesulphonamidophenyl)ethanol for treating urinary incontinence
US6703409B2 (en) 2′-Halo-3′,5′-dialkoxyphen-1′-yl-imino-2-imidazolidine and the use thereof as a drug
JP2007509868A (ja) 緊張性尿失禁及び/又は混合型尿失禁治療用医薬組成物
HK1126972A (en) Use of flibanserin in the treatment of sexual disorders
HK1157678A (zh) 弗利班西林在治疗性障碍中的用途
SK15672000A3 (sk) Použitie paroxetínu na liečenie generalizovaných anxióznych stavov